These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2582304)

  • 21. Effect of beta-FNA on opiate receptor binding: preliminary evidence for two types of mu receptors.
    Rothman RB; Bowen WD; Schumacher UK; Pert CB
    Eur J Pharmacol; 1983 Nov; 95(1-2):147-8. PubMed ID: 6321203
    [No Abstract]   [Full Text] [Related]  

  • 22. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.
    Caruso TP; Takemori AE; Larson DL; Portoghese PS
    Science; 1979 Apr; 204(4390):316-8. PubMed ID: 86208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics.
    Loew GH; Berkowitz DS
    J Med Chem; 1978 Jan; 21(1):101-6. PubMed ID: 73588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
    Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.
    Sayre LM; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.
    Spetea M; Nevin ST; Hosztafi S; Rónai AZ; Tóth G; Borsodi A
    Neurochem Res; 1998 Sep; 23(9):1211-6. PubMed ID: 9712193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels.
    Sayre LM; Larson DL; Fries DS; Takemori AE; Portoghese PS
    J Med Chem; 1983 Sep; 26(9):1229-35. PubMed ID: 6310111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro.
    Benyhe S; Hoffmann G; Varga E; Hosztafi S; Toth G; Borsodi A; Wollemann M
    Life Sci; 1989; 44(24):1847-57. PubMed ID: 2472540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.
    Williams CL; Bodnar RJ; Clark JE; Hahn EF; Burks TF; Pasternak GW
    J Pharmacol Exp Ther; 1988 Apr; 245(1):8-12. PubMed ID: 2452249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of phenolic bioisosterism in opiates: 3-sulfonamido analogues of naltrexone and oxymorphone.
    McCurdy CR; Jones RM; Portoghese PS
    Org Lett; 2000 Mar; 2(6):819-21. PubMed ID: 10754685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential affinity labels for the opiate receptor based on fentanyl and related compounds.
    Maryanoff BE; Simon EJ; Gioannini T; Gorissen H
    J Med Chem; 1982 Aug; 25(8):913-9. PubMed ID: 6288945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice.
    Ramabadran K
    Life Sci; 1982 Sep 20-27; 31(12-13):1253-6. PubMed ID: 6183549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors.
    Ohkawa S; DiGiacomo B; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1997 May; 40(11):1720-5. PubMed ID: 9171881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone.
    Hermens JM; Ebertz JM; Hanifin JM; Hirshman CA
    Anesthesiology; 1985 Feb; 62(2):124-9. PubMed ID: 2578752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
    France CP; Jacobson AE; Woods JH
    NIDA Res Monogr; 1984 Mar; 49():136-42. PubMed ID: 6207431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.